Pharmacologic Approaches to Diabetes Management: Glucagon-Like Peptide-1 Based Therapies
Tracking # 20-1368453
Course overview
Diabetes mellitus remains a significant public health problem as a leading cause of death and micro- and macrovascular morbidity. The management of diabetes continues to evolve as new research, technology, and treatments allow for enhanced patient care. It is vital for health care providers, including physicians, nurses, and pharmacists, to be current with diabetes care guidelines, including the pharmacologic management of diabetes mellitus. This course will review glucagon-like peptide-1-based therapies, including glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RAs. Dosing regimens, side effects, and monitoring parameters will be discussed. The role of GLP-1-based therapies within therapeutic regimens for patients with Type 2 diabetes mellitus will be discussed in the context of the updated American Diabetes Association Standards of Care in Diabetes 2023 guidelines.
Subject areas
This course counts toward the state boards and subject areas below.